Evidence map›Paper›PMID 39613983›Full record

ArticleAntonie van Leeuwenhoek2024

A description of Joostella sp. strain CR20 with potential biotechnological applications.

Muhammad Ramziuddin Zakaria, Maša Vodovnik, Maša Zorec, Kok Jun Liew, Lili Tokiman, Chun Shiong Chong

Abstract read
PubMed Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad Ramziuddin ZakariaDepartment of Biosciences, Faculty of Science, Universiti Teknologi Malaysia, 81310, Skudai, Johor, Malaysia.ORCID http://orcid.org/0000-0003-2191-7240
Maša VodovnikDepartment of Microbiology, Chair of Microbial Diversity, Microbiomics and Biotechnology, University of Ljubljana, Biotechnical Faculty, Jamnikarjeva 101, 1000, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0002-1189-2417
Maša ZorecDepartment of Microbiology, Chair of Microbial Diversity, Microbiomics and Biotechnology, University of Ljubljana, Biotechnical Faculty, Jamnikarjeva 101, 1000, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0003-1843-028X
Kok Jun LiewDepartment of Biosciences, Faculty of Science, Universiti Teknologi Malaysia, 81310, Skudai, Johor, Malaysia.ORCID http://orcid.org/0000-0002-3444-3278
Lili TokimanJohor National Parks Corporation, Kota Iskandar, 79575, Iskandar Puteri, Johor, Malaysia.
Chun Shiong ChongDepartment of Biosciences, Faculty of Science, Universiti Teknologi Malaysia, 81310, Skudai, Johor, Malaysia. cschong@utm.my.ORCID http://orcid.org/0000-0003-2165-4030

Funding

Ministry of Higher Education, Malaysia FRGS/1/2019/WAB13/UTM/02/1Slovenian Research Agency P4-0097 (C)Universiti Teknologi Malaysia Q.J130000.21A2.06E00
6 · The paper itself

Abstract

The underexplored halophilic genus Joostella within the Flavobacteriaceae family consists of only two species, both of which have received little attention for their potential biotechnological applications. In this study, we report the isolation and characterisation of a novel halophilic bacterium, strain CR20, using a genomic approach to investigate its biotechnological potential. Analysis of the 16S rRNA gene revealed that strain CR20 shares 97.5% and 96.2% sequence similarity with Joostella marina DSM 19592

Indexed as

BiotechnologyDNA, BacterialFlavobacteriaceaeGenome, BacterialPhylogenyRNA, Ribosomal, 16SBacterial Typing TechniquesBase CompositionFatty AcidsSequence Analysis, DNADNA, BacterialFatty AcidsRNA, Ribosomal, 16SBiotechnological applicationsFlavobacteriaceaeGalbibacterGenomeHalophileJoostella

Identifiers

PMID39613983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.